JP2017508716A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017508716A5 JP2017508716A5 JP2016541511A JP2016541511A JP2017508716A5 JP 2017508716 A5 JP2017508716 A5 JP 2017508716A5 JP 2016541511 A JP2016541511 A JP 2016541511A JP 2016541511 A JP2016541511 A JP 2016541511A JP 2017508716 A5 JP2017508716 A5 JP 2017508716A5
- Authority
- JP
- Japan
- Prior art keywords
- mer
- dialysis
- plasma exchange
- blood
- alginate oligomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1322777.2A GB201322777D0 (en) | 2013-12-20 | 2013-12-20 | Use of alginate oligomers as blood anticoagulants |
| GB1322777.2 | 2013-12-20 | ||
| PCT/GB2014/053808 WO2015092437A1 (en) | 2013-12-20 | 2014-12-19 | Use of alginate oligomers as blood anticoagulants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017508716A JP2017508716A (ja) | 2017-03-30 |
| JP2017508716A5 true JP2017508716A5 (https=) | 2019-12-05 |
| JP6626824B2 JP6626824B2 (ja) | 2019-12-25 |
Family
ID=50071308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016541511A Active JP6626824B2 (ja) | 2013-12-20 | 2014-12-19 | 血液抗凝固剤としてのアルギネートオリゴマーの使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11712448B2 (https=) |
| EP (1) | EP3082830B1 (https=) |
| JP (1) | JP6626824B2 (https=) |
| KR (1) | KR102256919B1 (https=) |
| CN (1) | CN105960243B (https=) |
| AU (1) | AU2014369463B2 (https=) |
| BR (1) | BR112016014321A8 (https=) |
| CA (1) | CA2934572C (https=) |
| DK (1) | DK3082830T3 (https=) |
| ES (1) | ES2779228T3 (https=) |
| GB (1) | GB201322777D0 (https=) |
| HU (1) | HUE048891T2 (https=) |
| PL (1) | PL3082830T3 (https=) |
| PT (1) | PT3082830T (https=) |
| RS (1) | RS60124B1 (https=) |
| RU (1) | RU2709814C1 (https=) |
| SI (1) | SI3082830T1 (https=) |
| WO (1) | WO2015092437A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10017471B2 (en) * | 2015-04-21 | 2018-07-10 | University Of Tennessee Research Foundation | Selective androgen receptor degrader (SARD) ligands and methods of use thereof |
| US11072668B2 (en) | 2017-01-03 | 2021-07-27 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto |
| JP7403152B2 (ja) | 2017-03-28 | 2023-12-22 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 生分解可能な抗菌性スキャフォールドとしての一酸化窒素放出性ポリアミノグリコシドおよびそれに関する方法背景 |
| AU2018369760B2 (en) | 2017-11-15 | 2025-01-02 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto |
| WO2019173539A1 (en) | 2018-03-06 | 2019-09-12 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto |
| JP7645546B2 (ja) | 2018-12-28 | 2025-03-14 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法 |
| GB201908639D0 (en) * | 2019-06-17 | 2019-07-31 | Algipharma Ipr As | Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense microstructure |
| US20220251627A1 (en) * | 2019-06-28 | 2022-08-11 | Zymo Research Corporation | Compositions for the stabilization of cell-free nucleic acids and methods thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2508433A (en) * | 1946-10-16 | 1950-05-23 | Wyeth Corp | Alginic acid sulfate anticoagulant |
| DE3152319C2 (de) * | 1980-09-03 | 1986-05-07 | Kyosei Pharmaceutical Co., Ltd., Hokkaido | Verwendung einer Lösung eines Salzes der Alginsäure zur Behandlung von Strahlenschäden und Ulcera |
| US5135955A (en) * | 1988-04-25 | 1992-08-04 | Eli Lilly And Company | Propanamine derivatives |
| KR920000459B1 (ko) | 1989-12-13 | 1992-01-14 | 재단법인 한국화학연구소 | 다당류 유도체가 도포된 인공혈관과 그 제조방법 |
| GB9221163D0 (en) | 1992-10-08 | 1992-11-25 | Nobipol And Protan Biopolymer | Dna compounds |
| US5646130A (en) | 1995-06-30 | 1997-07-08 | Ocean University Of Oingdao | Low molecular weight sulfated polysaccharides and uses thereof |
| NO305033B1 (no) | 1997-05-09 | 1999-03-22 | Algipharma As | Fremgangsmate for fremstilling av uronsyreblokker fra alginat |
| US7494669B2 (en) | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| NO20023581D0 (no) | 2002-07-26 | 2002-07-26 | Fmc Biopolymer As | Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat |
| CN1218965C (zh) | 2003-11-04 | 2005-09-14 | 武汉大学 | 海藻酸钠硫酸酯及其制备方法和用途 |
| GB2430881B (en) | 2005-10-06 | 2010-10-13 | Ntnu Technology Transfer As | Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity |
| KR101472765B1 (ko) | 2006-12-08 | 2014-12-15 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 경구용 Ｘａ 인자 억제제를 포함하는 단위 용량 제형 및 경구용 Ｘａ 인자 억제제를 사용하는 혈전증의 치료 방법 |
| GB0707096D0 (en) | 2007-04-12 | 2007-05-23 | Ntnu Technology Transfer As | Method |
| KR101690631B1 (ko) * | 2007-11-27 | 2017-01-09 | 알지파마 아이피알 에이에스 | 바이오필름 퇴치에 있어서의 알기네이트 올리고머의 용도 |
| CN101969978A (zh) * | 2008-02-22 | 2011-02-09 | 阿瑟拉生物技术公司 | 预防或治疗再狭窄的化合物和方法 |
| BRPI1011248A2 (pt) | 2009-06-03 | 2016-03-22 | Algipharma As | métodos in vitro ou ex vivo de superação de resitência a pelo menos um antibiótico, para combate de contaminação de um sítio e melhora da eficácia de um antibiótico de macrolídeo para inibir o crescimento de bactéria mdr gram negativa, uso de um oligômero de alginato e produto |
| KR101229055B1 (ko) * | 2010-06-07 | 2013-02-04 | 신라대학교 산학협력단 | 알긴산 분해능을 갖는 메틸로박테리움 속 균주 및 상기 균주를 이용한 알긴산 올리고머 제조방법 |
| CN102212148B (zh) | 2011-03-21 | 2013-07-17 | 中国海洋大学 | 一种静脉注射用抗血栓药及其制备方法和应用 |
| CN102382204B (zh) | 2011-08-31 | 2013-06-26 | 中国海洋大学 | 低分子量藻酸双酯钠及其制备方法和应用 |
| CN103142539B (zh) | 2013-03-21 | 2014-08-20 | 青岛正大海尔制药有限公司 | 一种藻酸双酯钠控释片及其制备方法 |
-
2013
- 2013-12-20 GB GBGB1322777.2A patent/GB201322777D0/en not_active Ceased
-
2014
- 2014-12-19 PT PT148158488T patent/PT3082830T/pt unknown
- 2014-12-19 BR BR112016014321A patent/BR112016014321A8/pt active Search and Examination
- 2014-12-19 AU AU2014369463A patent/AU2014369463B2/en active Active
- 2014-12-19 PL PL14815848T patent/PL3082830T3/pl unknown
- 2014-12-19 JP JP2016541511A patent/JP6626824B2/ja active Active
- 2014-12-19 CA CA2934572A patent/CA2934572C/en active Active
- 2014-12-19 RU RU2016126848A patent/RU2709814C1/ru active
- 2014-12-19 KR KR1020167019688A patent/KR102256919B1/ko active Active
- 2014-12-19 RS RS20200384A patent/RS60124B1/sr unknown
- 2014-12-19 ES ES14815848T patent/ES2779228T3/es active Active
- 2014-12-19 CN CN201480074815.2A patent/CN105960243B/zh active Active
- 2014-12-19 DK DK14815848.8T patent/DK3082830T3/da active
- 2014-12-19 HU HUE14815848A patent/HUE048891T2/hu unknown
- 2014-12-19 US US15/106,196 patent/US11712448B2/en active Active
- 2014-12-19 EP EP14815848.8A patent/EP3082830B1/en active Active
- 2014-12-19 WO PCT/GB2014/053808 patent/WO2015092437A1/en not_active Ceased
- 2014-12-19 SI SI201431543T patent/SI3082830T1/sl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017508716A5 (https=) | ||
| Park et al. | Fibrin-based biomaterial applications in tissue engineering and regenerative medicine | |
| Qi et al. | Surface modification of cardiovascular materials and implants | |
| CA2754101C (en) | Medical devices comprising gel for the treatment of vascular conditions | |
| Tous et al. | Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling | |
| AU2017394923B2 (en) | Methods and systems for treating a site of a medical implant | |
| Boisserand et al. | Biomaterial applications in cell‐based therapy in experimental stroke | |
| US4909799A (en) | Methods for preventing thrombosis; and surgical implant having reduced platelet deposition characteristics | |
| ES2779228T3 (es) | Uso de oligómeros de alginato como anticoagulantes sanguíneos | |
| Ohlow et al. | Pocket related complications in 163 patients receiving anticoagulation or dual antiplatelet therapy: D-Stat Hemostat™ versus standard of care | |
| AU2016266773B2 (en) | Composition for treating tissue lesions | |
| Rezaie et al. | Application of biomaterials | |
| Shah et al. | Bioactive sutures: advances in surgical suture functionalization | |
| JP2024532867A5 (https=) | ||
| Kumar et al. | Coatings on Surgical Tools and How to Promote Adhesion of Bio‐Friendly Coatings on Their Surfaces | |
| Lewis | Sensitive combination products: Devices, pharmaceuticals, and biologics | |
| Sua et al. | Injectable bioactive materials for myocardial regeneration | |
| Burdick et al. | Biomaterials for treating myocardial infarctions | |
| AU2013245532B2 (en) | Articles and methods of treating vascular conditions | |
| Faensen et al. | Aprotinin application has no negative effect on osseous implant integration: a biomechanical and histomorphometric investigation in a rat model | |
| RS67430B1 (sr) | Kompozicije hidroksietil-celuloznog gela koje sadrže bakteriofage | |
| BR112021021620B1 (pt) | Método para revestir implante com o uso de calor | |
| Dorsey et al. | Biomaterials for Treating Myocardial Infarctions | |
| HK1164171A (en) | Articles and methods of treating vascular conditions | |
| UA55726U (uk) | Спосіб лікування хворих на остеогенну саркому |